Matt Soellner
Assistant Professor of Chemistry, College of Literature, Science, and the Arts
Adjunct Research Associate Professor, Internal Medicine
[email protected]

Available to mentor
Matt Soellner
Assistant Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Selective and Potent PROTAC Degraders of c-Src Kinase.
      Mao W, Vandecan NM, Bingham CR, Tsang PK, Ulintz P, Sexton R, Bochar DA, Merajver SD, Soellner MB. ACS Chem Biol, 2024 Jan 19; 19 (1): 110 - 116. DOI:10.1021/acschembio.3c00548
      PMID: 38113191
    • Journal Article
      136P Molecular correlates of drug response to guide therapy in TNBC
      Merrill N, Vandecan N, Apfel A, Serhan H, Ulintz P, Bao L, Morikawa A, Soellner M, Merajver S. ESMO Open, 2023 Oct; 8 (1): 101946 DOI:10.1016/j.esmoop.2023.101946
    • Journal Article
      159P Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other NSCLC
      Merrill N, Udager A, Qin A, Lagisetty K, Aikins M, Bao L, Cheng X, Goo L, Kathawate V, Vandenburg B, Ulintz P, Qin Z, Liu A, Serhan H, Nagrath S, Hsu P, Soellner M, Merajver S. ESMO Open, 2023 Oct; 8 (1): 102008 DOI:10.1016/j.esmoop.2023.102008
    • Preprint
      Selective and potent PROTAC degraders of c-Src kinase
      Mao W, Vandecan N, Bingham C, Tsang PK, Ulintz P, Sexton R, Bochar D, Merajver S, Soellner M. ChemRxiv, DOI:10.26434/chemrxiv-2023-zncbf
    • Proceeding / Abstract / Poster
      Personalized medicine for brain metastases (BrMets) through patient-derived organoid (PDO) drug testing.
      Morikawa A, Serhan H, Udager AM, Bao L, Qin Z, Cheng X, Heth J, Soellner M, Merajver S, Merrill N. JCO Global Oncology, 2023 Aug; 9 (Supplement_1): 11 - 11. DOI:10.1200/go.2023.9.supplement_1.11
    • Proceeding / Abstract / Poster
      Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other non-small cell lung cancers.
      Merrill N, Udager AM, Qin A, Lagisetty K, Aikins M, Bao L, Cheng X, Goo L, Kathawate V, Vandenburg B, Ulintz P, Qin Z, Liu A, Serhan H, Nagrath S, Hsu P, Soellner M, Merajver S. JCO Global Oncology, 2023 Aug; 9 (Supplement_1): 146 - 146. DOI:10.1200/go.2023.9.supplement_1.146
    • Additional Scholarship
      Data from Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment
      Morikawa A, Li J, Ulintz P, Cheng X, Apfel A, Robinson D, Hopkins A, Kumar-Sinha C, Wu Y-M, Serhan H, Verbal K, Thomas D, Hayes DF, Chinnaiyan AM, Baladandayuthapani V, Heth J, Soellner MB, Merajver SD, Merrill N. 2023 Jun 21; DOI:10.1158/2767-9764.c.6689056
    • Additional Scholarship
      Data from Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment
      Morikawa A, Li J, Ulintz P, Cheng X, Apfel A, Robinson D, Hopkins A, Kumar-Sinha C, Wu Y-M, Serhan H, Verbal K, Thomas D, Hayes DF, Chinnaiyan AM, Baladandayuthapani V, Heth J, Soellner MB, Merajver SD, Merrill N. 2023 Jun 21; DOI:10.1158/2767-9764.c.6689056.v2